Paediatric trials are a core part of clinical development. Not only is there a commercial incentive to develop paediatric treatments, but there is also a moral imperative. Dr Malgorzata Szerszeniewska of EastHORN describes how, every month, new precedents are set and regulations clarified for the practical purpose of attracting high-quality paediatric clinical research in Eastern Europe.